Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamine
US-2024400512-A1 · Dec 5, 2024 · US
US9475831B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9475831-B2 |
| Application number | US-201615002258-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 20, 2016 |
| Priority date | Jan 19, 2011 |
| Publication date | Oct 25, 2016 |
| Grant date | Oct 25, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A compound has Formula I: A, B, C, D, W, X, Y, and Z are independently selected from hydrogen, optionally substituted C 1 -C 6 alkyl, optionally substituted C 1 -C 6 alkoxy, aryl, aldehyde, protected aldehyde, CH, N, O, S, null, and bond; Q is selected from aldehyde, protected aldehyde, and null, at least one of A, B, C, D, W, X, Y, Z, or Q is an aldehyde or protected aldehyde; the bonds between each of A-B, B-C, C-D, W-X, X-Y, and Y-Z are selected from single bond, double bond, triple bond, and no bond; L is a linker selected from a C 1 -C 12 alkyl, aralkyl, and aryl, any of which is optionally substituted; one or more methylene unit (CH 2 ) of the C 1 -C 12 alkyl is optionally replaced by any combination of oxygen, carbonyl(C═O), and NH; and R 1 and R 2 are independently selected from —NR 3 R 4 , halogen, C 1 -C 8 alkoxy, aralkoxy, alkenyloxy, alkynyloxy, and OCH 2 CH 2 CN; R 3 and R 4 are independently a C 1 -C 4 , straight chain or branched alkyl group.
Opening claim text (preview).
What is claimed is: 1. A compound of Formula III: wherein, W, X, Y, and Z comprise a fused ring system selected from the group consisting of a furan, a thiophene, a pyridazine, a pyrazine, and a pyrimidine; A is selected from the group consisting of aryl, hydrogen, hydroxyl, hydroxyalkyl, a C 1 -C 4 straight chain or branched alkyl and alkoxy; Q is an aldehyde or protected aldehyde; L is a linker selected from a C 1 -C 12 alkyl, aralkyl, and aryl, any of which is optionally substituted; wherein one or more methylene unit (CH 2 ) unit of said C 1 -C 12 alkyl is optionally replaced by any combination of oxygen, carbonyl (C═O), and NH; and R 1 and R 2 are independently selected from the group consisting of —NR 3 R 4 , halogen, C 1 -C 8 alkoxy, aralkoxy, alkenyloxy, alkynyloxy, and OCH 2 CH 2 CN; wherein R 3 and R 4 are independently a C 1 -C 4 , straight chain or branched alkyl group. 2. The compound of claim 1 , wherein the protected aldehyde is selected from the group consisting of an acetal, an aminal, a dithioacetal, a protected hemiaminal, an alkene, and a protected hemithioacetal. 3. The compound of claim 1 , wherein A is hydrogen or methyl, Q is a protected aldehyde, R 1 is N-iPr 2 , and R 2 is OCH 2 CH 2 CN. 4. The compound of claim 1 , wherein A is a hydroxyl, alkoxy or hydroxyalkyl, Q is a protected aldehyde, R 1 is N-iPr 2 , and R 2 is OCH 2 CH 2 CN. 5. A compound of Formula IV: wherein, W, X, Y, and Z comprise a fused ring system selected from the group consisting of a furan, a thiophene, a pyridazine, a pyrazine, and a pyrimidine; A is selected from the group consisting of aryl, hydrogen, hydroxyl, alkoxy hydroxyalkyl, and a C 1 -C 4 straight chain or branched alkyl; Q is an aldehyde or protected aldehyde; L is a linker selected from a C 1 -C 12 alkyl, aralkyl, and aryl, any of which is optionally substituted; wherein one or more methylene unit (CH 2 ) of said C 1 -C 12 alkyl is optionally replaced by any combination of oxygen, carbonyl (C═O), and NH; and Nu is a nucleic acid. 6. The compound of claim 5 , wherein the protected aldehyde is selected from the group consisting of an acetal, an aminal, a dithioacetal, a protected hemiaminal, an alkene, and a protected hemithioacetal. 7. The compound of claim 5 , wherein A is hydrogen or methyl, Q is a protected aldehyde, Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-linked nucleic acid, and a 3′-phosphate linked modified nucleic acid. 8. The compound of claim 5 , wherein A is hydrogen or methyl, Q is a protected aldehyde, Nu is selected from the group consisting of a 5′-phosphate-linked nucleic acid, a 5′-thiophosphate-linked nucleic acid, and a 5′-phosphate linked modified nucleic acid. 9. The compound of claim 5 , wherein A is hydroxyl, alkoxy, or hydroxyalkyl, Q is a protected aldehyde, and Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-linked nucleic acid, and a 3′-phosphate linked modified nucleic acid. 10. The compound of claim 5 , wherein A is hydroxyl, alkoxy or hydroxyalkyl, Q is a protected aldehyde, and Nu is selected from a group consisting of a 5′-phosphate-linked nucleic acid, a 5′-thiophosphate-linked nucleic acid, and a 5′-phosphate linked modified nucleic acid. 11. A support-bound nucleic acid of Formula V: wherein, W, X, Y, and Z comprise a fused ring system selected from the group consisting of a furan, a thiophene, a pyridazine, a pyrazine, and a pyrimidine; A is selected from the group consisting of aryl, hydrogen, hydroxyl, alkoxy hydroxyalkyl, and a C 1 -C 4 straight chain or branched alkyl; L is a linker selected from a C 1 -C 12 alkyl, aralkyl, and aryl, any of which is optionally substituted; wherein one or more methylene unit (CH 2 ) of said C 1 -C 12 alkyl is optionally replaced by any combination of oxygen, carbonyl (C═O), and NH; Nu is a nucleic acid; Su is a support material; and B is a single or double bond, such that when B is a single bond, R is hydrogen and when B is a double bond R is null. 12. The support-bound nucleic acid of claim 11 , wherein A is hydrogen or methyl, Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-linked nucleic acid, and a 3′-phosphate linked modified nucleic acid. 13. The support-bound nucleic acid of claim 11 , wherein A is hydrogen or methyl, Nu is selected from the group consisting of a 5′-phosphate-linked nucleic acid, a 5′-thiophosphate-linked nucleic acid, and a 5′-phosphate linked modified nucleic acid. 14. The support-bound nucleic acid of claim 11 , wherein A is hydroxyl, alkoxy, or hydroxyalkyl, and Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-linked nucleic acid, and a 3′-phosphate linked modified nucleic acid. 15. The support-bound nucleic acid of claim 11 , wherein A is hydroxyl, alkoxy or hydroxyalkyl, and Nu is selected from the group consisting of a 5′-phosphate-linked nucleic acid, a 5′-thiophosphate-linked nucleic acid, and a 5′-phosphate linked modified nucleic acid. 16. The support-bound nucleic acid of claim 11 , wherein the support material is selected from the group consisting of a silica bead, CPG glass, a polymer bead, a microfluidic cell, and a 96 well plate. 17. The support-bound nucleic acid of claim 16 , wherein said polymer bead comprises a polymer selected from the group consisting of polystyrene, agarose, polyacrylate, and polyacrylamide. 18. A method of immobilizing a nucleic acid comprising forming a Schiff-base product by reaction of a compound of Formula IV: wherein, W, X, Y, and Z comprise a fused ring system selected from the group consisting of a furan, a thiophene, a pyridazine, a pyrazine, and a pyrimidine; A is selected from the group consisting of aryl, hydrogen, hydroxyl, alkoxy hydroxyalkyl, and a C 1 -C 4 straight chain or branched alkyl; Q is an aldehyde (alkene) or protected aldehyde; L is a linker selected from a C 1 -C 12 alkyl, aralkyl, and aryl, any of which is optionally substituted; wherein one or more methylene unit (CH 2 ) of said C 1 -C 12 alkyl is optionally replaced by any combination of oxygen, carbonyl (C═O), and NH; and Nu is a nucleic acid; with a support material displaying an amino or masked amino functional group. 19. The method of claim 18 , wherein A is hydrogen or methyl, Q is a protected aldehyde, Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-linked nucleic acid, and a 3′-phosphate linked modified nucleic acid. 20. The method of claim 18 , wherein A is hydrogen or methyl, Q is a protected aldehyde, Nu is selected from the group consisting of a 5′-phosphate-linked nucleic acid, a 5′-thiophosphate-linked nucleic acid, and a 5′-phosphate linked modified nucleic acid. 21. The method of claim 18 , wherein A is hydroxyl, alkoxy, or hydroxyalkyl, Q is a protected aldehyde, and Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-lin
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids · CPC title
having the nitrogen atoms in the positions 1 and 2 · CPC title
having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate · CPC title
having the nitrogen atoms in positions 1 and 3 · CPC title
condensed with carbocyclic rings or carbocyclic ring systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.